Sheridan animal sciences company hires new CEO
Brian Barker was previously CEO of Westfield-based seed and bioscience company AgReliant Genetics.
Read MoreBrian Barker was previously CEO of Westfield-based seed and bioscience company AgReliant Genetics.
Read MoreThe company’s product is designed to neutralize a disease in broiler chickens that causes an estimated $6 billion in annual losses worldwide.
Read MoreIn its lawsuit, Corteva accused Inari Agriculture Inc. of taking Corteva’s patent-protected seeds, making slight genetic modifications and preparing to commercialize them under its own name.
Telix is an Australia-based biotechnology company with its U.S. headquarters in Fishers.
Pharmaceutical Product Development, a subsidiary of Thermo Fisher Scientific Inc., is planning to hire 100 to 150 employees at the facility.
Medical experts hope mRNA vaccines make it easier to respond quicker to changes in the flu strain because they are faster to develop than traditional shots.
Steve Hoerter, who was previously executive chairman of the company’s board of directors, has succeeded Kent Hawryluk as CEO and board chair.
The Indiana State Department of Toxicology saw an all-time high number of cases submitted for blood analysis in 2025.
The company, which is owned by biopharmaceutical giant Bristol Myers Squibb Co., is working on an incentive package with Whitestown officials that includes tax abatements for construction and new equipment for two buildings.
The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world,” officials said.
The nearly $24.3 million project, being led by Bloomington-based Applied Research Institute, or ARI, will serve as a biomanufacturing workforce training and innovation center when complete.
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
Seeking to position Indiana as a global leader in agritechnology and life sciences, Gov. Mike Braun unveiled a lofty goal in a public announcement Tuesday morning.
IU Inc. was approved unanimously by the university’s board of trustees during its monthly meeting Friday in Indianapolis.
The $50 billion company is considering dividing its seed and pesticide businesses into separate companies, the Wall Street Journal reported
Syndeio Biosciences sees burgeoning potential to treat mental health and cognitive conditions, including Alzheimer’s and depression, with therapies that target the almost countless minuscule brain synapses that give people the ability to think and function.
Indianapolis-based Gate Neurosciences, which is in clinical trials of a medicine to treat depression, plans to acquire California-based biotech startup Boost Neuroscience.
Known as IU LAB and supported by a $138 million grant from the Lilly Endowment, the IU Launch Accelerator for Biosciences will be based at the 16 Tech Innovation District.
The gift is the largest grant that Indiana University has ever received in support of research and development. IU President Pamela Whitten said the funding will help “change the very landscape of our capital city and state.”
Corteva, the Indianapolis-based seed and crop protection giant, formed a joint venture with the startup, Pairwise, based in Durham, North Carolina, aimed at increasing crop yield for food, fuel and fiber production.
The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.
MBX is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.